Latest Breaking News On - Sarcoma center - Page 4 : comparemela.com

Investigational drug attacks synovial sarcoma, a rare type of tumor – Washington University School of Medicine in St Louis

Investigational drug attacks synovial sarcoma, a rare type of tumor – Washington University School of Medicine in St Louis
wustl.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wustl.edu Daily Mail and Mail on Sunday newspapers.

Briana vanWilliamg hawkinsJulia evangelou straitSchool of medicineSiteman cancer center at barnesSarcoma centerWashington university school of medicineVan tine labResearchers at washington university school of medicineWashington universityClinical cancer researchWashington university schoolClinical cancerCancer centerBarnes jewish hospitalSiteman kids

Investigational drug attacks synovial sarcoma, a rare type of tumor - The Source - Washington University in St Louis

A new study from Washington University School of Medicine describes a potential new therapy for synovial sarcoma, a rare tumor of soft tissues.

Briana vanWilliamg hawkinsWashington universityResearchers at washington university school of medicineSiteman cancer center at barnesSarcoma centerWashington university school of medicineClinical cancer researchWashington university schoolClinical cancerSiteman cancer centerBarnes jewish hospitalSiteman kidsLouis childrenVan tineNeidorff family

Scientists develop new way to attack synovial sarcoma using an investigational drug

Researchers at Washington University School of Medicine in St. Louis have developed a way to attack synovial sarcoma -; a rare tumor of soft tissues, such as ligaments and muscles -; using an investigational drug that triggers cell death.

Briana vanWilliamg hawkinsEmily hendersonWashington universityResearchers at washington university school of medicineSiteman cancer center at barnesSarcoma centerWashington university school of medicineClinical cancer researchWashington university schoolClinical cancerCancer centerBarnes jewish hospitalSiteman kidsLouis childrenVan tine

Investigational drug attacks synovial sarcoma, rare type of tumor

Investigational drug attacks synovial sarcoma, rare type of tumor
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Briana vanWilliamg hawkinsWashington universityResearchers at washington university school of medicineSiteman cancer center at barnesSarcoma centerWashington university school of medicineClinical cancer researchWashington university schoolClinical cancerCancer centerBarnes jewish hospitalSiteman kidsLouis childrenVan tineNeidorff family

Ripretinib Safer Than Sunitinib for GIST, Fails to Improve PFS

The findings suggest that ripretinib (Qinlock) provides a similar PFS benefit but may come with notably better tolerability compared with sunitinib.

United statesDana farber cancer instituteMichaelc heinrichAmerican society of clinical oncology plenary seriesTheseus pharmaceuticalsOregon health science universityHarvard medical schoolDeciphera pharmaceuticalsSarcoma center at dana farber cancer instituteOregon healthScience universityAmerican societyClinical oncology plenarySarcoma centerHarvard medicalBlueprint medicines